Actively Recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Led by Eli Lilly and Company · Updated on 2026-04-17
100
Participants Needed
26
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to see how well LY3938577 works and how safe it is compared to degludec in people with type 2 diabetes. Participation in the study will last about 26 weeks.
CONDITIONS
Official Title
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have type 2 diabetes
- Are receiving 20 units or more of basal insulin per day and 55 units or less per day and 1.5 units or less per kilogram per day at screening
- Have hemoglobin A1c (HbA1c) between 7.5% and 10.5% inclusive
- Have a body mass index (BMI) of 20 or higher and less than 35 kilograms per square meter (kg/m2)
You will not qualify if you...
- Have type 1 diabetes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 26 locations
1
Tucson Clinical Research Institute
Tucson, Arizona, United States, 85712
Actively Recruiting
2
Encompass Clinical Research
Spring Valley, California, United States, 91978
Actively Recruiting
3
University Clinical Investigators, Inc.
Tustin, California, United States, 92780
Actively Recruiting
4
Tampa Bay Medical Research
Clearwater, Florida, United States, 33761
Actively Recruiting
5
Encore Medical Research
Hollywood, Florida, United States, 33024
Actively Recruiting
6
Clinical Research of Central Florida
Lakeland, Florida, United States, 33805
Actively Recruiting
7
Encore Medical Research - Weston
Weston, Florida, United States, 33331
Actively Recruiting
8
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, United States, 50266
Actively Recruiting
9
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
10
Accellacare - Wilmington
Wilmington, North Carolina, United States, 28401
Actively Recruiting
11
AMR Clinical
Norman, Oklahoma, United States, 73069
Actively Recruiting
12
Tribe Clinical Research, LLC
Greenville, South Carolina, United States, 29607
Actively Recruiting
13
Holston Medical Group
Bristol, Tennessee, United States, 37620
Actively Recruiting
14
Texas Diabetes & Endocrinology, P.A.
Austin, Texas, United States, 78749
Actively Recruiting
15
Velocity Clinical Research, Dallas
Dallas, Texas, United States, 75230
Actively Recruiting
16
Juno Research
Houston, Texas, United States, 77040
Actively Recruiting
17
Southern Endocrinology Associates
Mesquite, Texas, United States, 75149
Actively Recruiting
18
Consano Clinical Research, LLC
Shavano Park, Texas, United States, 78231
Actively Recruiting
19
Texas Valley Clinical Research
Weslaco, Texas, United States, 78596
Actively Recruiting
20
Chrysalis Clinical Research
St. George, Utah, United States, 84790
Actively Recruiting
21
Cicemo Srl
Buenos Aires, Argentina, 1424
Actively Recruiting
22
CIPREC
Buenos Aires, Argentina, C1119ACN
Actively Recruiting
23
Mautalen Salud e Investigación
Buenos Aires, Argentina, C1128AAF
Actively Recruiting
24
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Buenos Aires, Argentina, C1425AGC
Actively Recruiting
25
Instituto Centenario
CABA, Argentina, 1204
Actively Recruiting
26
Instituto Médico Catamarca IMEC
Rosario, Argentina, 2000
Actively Recruiting
Research Team
T
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
P
Physicians interested in becoming principal investigators please contact
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here